In fact, the expression of maspin mostly appeared to be correlated with better prognosis clinically in prostate, bladder, lung, gastric, colorectal, head and neck, and thyroid cancers and melanoma (Berardi et al., 2013; Kapoor, 2014). This evidence concerns the gene SERPINB5 and thyroid gland carcinoma.